Providence Regional Cancer Partnership (Site 0016)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Kidney cancer

Closed trials

• Completed

  Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

  NCT03142334· Phase 3· Merck Sharp & Dohme LLC· Source